Adjusting Levothyroxine Dosage for Elevated TSH

Assessment of Current Status

The American Medical Association recommends that the levothyroxine dosage should be increased to bring the serum TSH into the reference range for a patient with subclinical hypothyroidism, with an elevated TSH and a T4 level in the lower normal range 1
Inadequate replacement therapy on the current dose of levothyroxine is indicated by an elevated TSH, suggesting the need for dose adjustment 2
The dosage should be adjusted to bring the serum TSH into the reference range when subclinical hypothyroidism is noted in levothyroxine-treated patients 1

A TSH level greater than 4.5 mIU/L with normal T4 in a patient already on levothyroxine indicates the need for dose adjustment 1
The American Medical Association suggests that for patients already on levothyroxine with elevated TSH, the first step is to assess compliance and appropriateness of dose 3

The American Medical Association recommends monitoring serum TSH 6-8 weeks after any dosage change 1

Age and cardiac status affect dosage adjustments, with smaller incremental increases (12.5 mcg) recommended for elderly patients or those with cardiac disorders, and larger incremental increases (25 mcg) may be appropriate for younger patients without cardiac risk 1, 4
The target TSH range is controversial, but if the patient continues to have symptoms of hypothyroidism despite TSH in the upper half of normal range, it is reasonable to increase the dose to bring TSH into the lower portion of the reference range 1

Overlooking compliance issues before increasing dose can lead to inadequate treatment, as recommended by the American Medical Association 3
Ignoring factors that may increase levothyroxine requirements, such as pregnancy, which requires more frequent monitoring, can lead to under-replacement 5
Excessive dosing can lead to iatrogenic hyperthyroidism, which can increase the risk of atrial fibrillation and bone loss, as reported by the American Medical Association 6